daily equity-report by epic research 4 april 2013

Download Daily equity-report by epic research 4 april 2013

Post on 20-Oct-2014

232 views

Category:

Documents

1 download

Embed Size (px)

DESCRIPTION

 

TRANSCRIPT

-=6 HEADLINES

Indian Market

Indian equity markets were down 1.31%

Nifty up by 75.20 pts and settle at 5672.90

Sensex down by 239.31 pts at 18801.64

Bank Nifty down by 179.30 pts at 11344.10

Global Market

European markets were down with FTSE down by 23.73 closed at 6466 ,CAC down by 6.34 closed at 3799 and DAX down 7.48 closed at 7936.

Dow future was up by 12 closed at

14596.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

4TH APRIL 2013

HEADLINES

Growth in services sector slowest since

Oct 2011: Poll

Adani Power, Tata Power, Rel Power up

on CERC ruling

Honda eyeing Bajaj, Hero's lunch; aims

43% growth in FY14

See 8% growth by 2015; can absorb

$50-bn FDI annually: FM

FIIs and DIIs

CATEGORY DATE BUY SELL NET

FII 3-Apr-13 2353.92 2722.31 -368.39

DII 3-Apr-13 830.24 792.51 37.73

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 5970 5876 5782 5727 5688 5633 5594 5500 5406

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

Key benchmark indices snapped four day winning streak after a private survey showed growth in the services sector hit 17-month low in March 2013 and as European stocks dropped. The barometer index,

the S&P BSE Sensex, fell below the psychological 19,000 mark. The Sensex and the 50-unit CNX

Nifty, both, hit their lowest level in nearly one week. Index heavyweight Reliance Industries (RIL)

extended losses in late trade. Another index heavyweight and cigarette maker ITC edged lower in

choppy trade. The Sensex was provisionally down 263.40 points or 1.38%, up about 55 points from the

day's low and off close to 260 points from the day's high. The market breadth turned negative from

positive in late trade. Realty stocks reversed intraday gains. Auto stocks edged lower.

The market edged lower in early trade. The market trimmed initial losses in morning trade. The Sensex hovered in negative terrain after hitting fresh intraday low in mid-morning trade. The market trimmed

intraday losses in early afternoon trade. Key benchmark indices hit fresh intraday low in afternoon

trade after weak opening of European markets. The Sensex trimmed losses in mid-afternoon trade. The

market tumbled to hit fresh intraday low in late trade

Shares of Hero MotoCorp declined 2.55%.Realty stocks reversed intraday gains. D B Realty, Sobha Developers, DLF, HDIL, and Unitech dropped by 0.01% to 4.05%..

S&P BSE Sensex was down 263.40 points or 1.38% to 18,777.55. The CNX Nifty was down 83.20 points or 1.45% to 5,664.90

STOCKS TO WATCH

BAJAJ AUTO

HERO MOTO

ADANI POWER

AURO PHARMA

SCRIPS IN BAN PERIOD

WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Bearish

Strategy: Sell on rise

Support: 5610

Resistance: 5750

BANK NIFTY

Bank Nifty looks Bearish

Strategy: Sell on rise

Support: 11280

Resistance: 11400

460

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH ADANI ENT B TARGET HIT

CASH APOLLO TYRE B NOT

EXECUTED

FUTURE AUROBINDO

PHARMA B TARGET HIT

FUTURE DENA BANK B TARGET HIT

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

Sun Pharma

864.30 1307.97 851.30 13.00 1.53

NTPC 145.40 8074.30 144.10 1.30 0.90

Ranbaxy Labs.

453.05 643.81 449.40 3.65 0.81

Tata Power

95.95 5315.13 95.30 0.65 0.68

ITC 307.60 4825.34 307.15 0.45 0.15

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

NMDC 130.20 4558.89 136.25 -6.05 -4.44

DLF 244.85 9312.64 255.80 -10.95 -4.28

Bharti Airtel

280.80 5649.12 291.80 -11.00 -3.77

Tata Motors

257.20 13014.50 267.20 -10.00 -3.74

Bajaj Auto

1692.35 644.27 1752.70 -60.35 -3.44

6

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

ADANI POWER BUY 47.80 48.30 48.80 47.30

BHARAT FORGE BUY 215.20 217.20 219.20 213.20

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

AUROBINDO PHARMA

BUY 161.20 163.20 165.20 159.20

ANDHRA BANK SELL 96.70 96.20 95.70 97.20

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.